Zhejiang Jolly Pharmaceutical (300181.SZ) Earnings Analysis

Zhejiang Jolly Pharmaceutical (300181.SZ) has no confirmed upcoming earnings date. Trailing P/E 15.21.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does 300181.SZ next report earnings?

No confirmed upcoming earnings date is currently scheduled for 300181.SZ. This page updates as the calendar is published.

300181.SZ earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-04-270.28 CNYn/an/an/a
2025-10-270.1971 CNYn/an/an/a
2025-04-250.2583 CNYn/an/an/a
2025-03-090.1235 CNYn/an/an/a
2024-10-270.1796 CNYn/an/an/a
2024-07-290.219 CNYn/an/an/a

300181.SZ valuation and analyst view

Trailing P/E15.21
Trailing EPS0.92737 CNY
Price / book2.93
Dividend yield2.45%
Market cap9.95B

Limited or no published sell-side analyst coverage for this symbol.

Related research pages

Frequently asked questions

When is Zhejiang Jolly Pharmaceutical (300181.SZ)'s next earnings date?

No confirmed upcoming earnings date is currently scheduled for 300181.SZ. This page updates as the calendar is published.

Did 300181.SZ beat earnings last quarter?

Consensus estimate data was not available for 300181.SZ's 2026-04-27 report.

What is 300181.SZ's current P/E ratio and EPS?

300181.SZ trades at a trailing P/E of 15.21 on trailing EPS of 0.9273722548266498 CNY.

What do analysts rate 300181.SZ?

300181.SZ has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.